According to a market report by Lucintel, the future of the global corneal cross linking device market looks promising with opportunities in the hospital, eye clinic, and ambulaotory surgery center markets. The global corneal cross linking device market is expected to reach an estimated $0.3 billion by 2030 from $0.2 billion in 2023, at a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are increased prevalence of keratoconus and rising demand for advanced linking devices to improve patient comfort.
A more than 150-page report to understand trends, opportunity and forecast in corneal cross linking device market to 2030 by type (standard corneal cross-linking, corneal cross-linking plus, and accelerated cross-linking), method (epithelium-off method and epithelium-on method), application (keratoconus, pellucid marginal degeneration, refractive surgery ectasia, and others), end use (hospitals, ambulatory surgical centers, eye clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that standard corneal cross-linking is expected to witness highest growth over the forecast period.
Hospital is expected to witness highest growth over the forecast period.
Download sample by clicking on corneal cross linking device market
APAC is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure and presence of major customer base in the region.
Glaukos, EMAGine, Peschke, IROMED, IVIS Technologies, AJL Ophthalmic are the major suppliers in the corneal cross linking device market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Bentonite Nano Clay Powder Market
Coenzyme Q10 Nano-Emulsion Market
Horizontal Nano Bead Mill Market
Nano Bismuth Oxide Powder Market
Nano Boron Carbide Market
Nano Bubble Stone Market